IND Swift Laboratories Ltd
Mr. Nav Rattan Munjal is the Chairman Cum Managing Director of the Ind-Swift Group. His tenure has witnessed exponential growth of organization both domestically and internationally. Mr Munjal is the strategic mind behind the success story of their organization.
His dynamic leadership has established Ind-Swift as India's leading pharmaceutical group. As an inspiring philanthropist, Mr Munjal's focus has always been on building a socially responsible and sustainable organization that propel development of Individuals, Society , Nation and World at large.
He has served as Ex-Chairman of Pharmaceutical Export Promotion Council of India; Ex-President of Indian Drugs Manufacturers' Association (IDMA), Ex-Vice President (North) of Bulk Drugs Manufacturers Association, Ex-Member of Board of Trade (BOT) - Ministry of Commerce & Industry Ex-Member of Board of Governors of National Institute of Pharmaceutical Education and Research (NIPER).
Today the group continues to expand at exponential rates under noble directional guidance of Mr Munjal.
This person is not in any offices
IND Swift Laboratories Ltd
Ind-Swift Laboratories Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs). The Company operates through the bulk drugs and pharmaceuticals segment. The Company has a product portfolio of approximately 50 products across approximately 15 therapeutic segments. It manufactures Clarithromycin powder/granules, Atorvastatin Calcium Crystalline, Roxithromycin and Nitazoxanide. It also manufactures Nateglinide, Dutasteride, Moxifloxacin and Imatinib Mesylate. The Company offers products for various therapeutic categories, such as macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsyhotic, bone resorption inhibitor, hyperparathyrodism, antineoplastic, treatment of premature ejaculation and nootropic. Its research and development projects include Crams for API Development Medicinal Chemistry development for various discovery projects. The Company also operates a menthol and mint products manufacturing facility.